Reuven Yeganeh sold $4.9M of HLSQ
director, owner at BiomX Inc.. 980,000 shares at an average of $5.00, traded Mar 16, 2026, filed Mar 18, 2026.
Score components
- +15RoleDirector
- +25Trade size$4.9M at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -63.5%, 3m -89.1%, 6m -85.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-26-031016, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | CConversion Common Stock, $0.0001 par value per shareindirect: Pyu Pyu Capital LLC | +450,000 | $2.00 | $900k | 450,000 | Mar 18, 2026 |
| Mar 16, 2026 | SOpen-market sale Common Stock, $0.0001 par value per shareindirect: Pyu Pyu Capital LLC | -450,000 | $5.00 | $2.3M | 0 | Mar 18, 2026 |
| Mar 17, 2026 | CConversion Common Stock, $0.0001 par value per shareindirect: Pyu Pyu Capital LLC | +530,000 | $2.00 | $1.1M | 530,000 | Mar 18, 2026 |
| Mar 17, 2026 | SOpen-market sale Common Stock, $0.0001 par value per shareindirect: Pyu Pyu Capital LLC | -530,000 | $5.00 | $2.6M | 0 | Mar 18, 2026 |
| Mar 16, 2026 | CConversion Series Y Convertible Preferred Stockderivativeindirect: Pyu Pyu Capital LLC | -900 | $0.00 | $0 | 1,060 | Mar 18, 2026 |
| Mar 17, 2026 | CConversion Series Y Convertible Preferred Stockderivativeindirect: Pyu Pyu Capital LLC | -1,060 | $0.00 | $0 | 0 | Mar 18, 2026 |
| Mar 16, 2026 | SOpen-market sale Common Stock Purchase Warrantsderivativeindirect: Pyu Pyu Capital LLC | -1,300,000 | $5.00 | $6.5M | 2,000,000 | Mar 18, 2026 |
| Mar 16, 2026 | SOpen-market sale Common Stock Purchase Warrantsderivativeindirect: Pyu Pyu Capital LLC | -2,000,000 | $5.24 | $10M | 1,700,000 | Mar 18, 2026 |
| Mar 16, 2026 | SOpen-market sale Common Stock Purchase Warrantsderivativeindirect: Pyu Pyu Capital LLC | -1,700,000 | $4.76 | $8.1M | 0 | Mar 18, 2026 |
Related signals
Other insiders at BiomX Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 60Notable | HLSQsell BiomX Inc. | Reuven Yeganeh director, owner | $3.4M 670,000 shares | -223% | |
| 12Weak | HLSQsell BiomX Inc. | OrbiMed Israel BioFund GP Limited Partnership owner | $9,280 24,344 shares | -0% | |
| 35Weak | HLSQsell BiomX Inc. | Assaf Oron Chief Business Officer | $4,072 10,914 shares | -100% | |
| 20Weak | HLSQsell BiomX Inc. | Chidozie Ugwumba other | $184k 288,619 shares | -8% | |
| 18Weak | HLSQsell BiomX Inc. | Chidozie Ugwumba other | $107k 277,247 shares | -8% | |
| 13Weak | HLSQsell BiomX Inc. | Chidozie Ugwumba other | $27k 74,955 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.